VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2023 | Surgery for early metastatic seminoma

Siamak Daneshmand, MD, University of Southern California, Los Angeles, CA, talks on surgery as a treatment option for patients with early metastatic seminoma. A trial was carries out including patients with early metastatic seminoma who had no prior treatment. The recurrence-free survival (RFS) was 81% with a 2-year minimum follow-up, with 78% of patients cured with surgery alone. Overall, the trial demonstrated promising results, presenting surgery as a possible alternative treatment option to systemic therapy. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter